TABLE 1.
Characteristics of HIV-infected pregnant women at late pregnancy antiretroviral therapy intervention, 2009–2015.
| Overall (N=101) |
INSTI (N=39) |
Other (N=62) |
p-value | |
|---|---|---|---|---|
| Race & Ethnicity | ||||
| White, non-Hispanic | 16 (16) | 5 (13) | 11 (18) | 0.47 |
| White, Hispanic | 10 (10) | 4 (11) | 6 (10) | |
| Black | 73 (72) | 28 (72) | 45 (73) | |
| Other | 2 (2) | 2 (5) | 0 (0) | |
| Parity* | ||||
| 0 | 38 (38) | 17 (44) | 21 (34) | 0.63 |
| ≥1 | 62 (61) | 22 (56) | 40 (65) | |
| Maternal Age (years)* | 27 (23, 32) | 29 (23, 34) | 26 (23, 31) | 0.33 |
| Gestational Age (weeks) | 29.0 (26.0–33.6) | 33.6 (29.9–36.1) | 27.5 (25.4–30.7) | <0.01 |
| Body Mass Index (kg/m2) | 29.6 (26.3–35.2) | 27.7 (24.4–35.0) | 30.5 (26.6–35.3) | 0.26 |
| No ART at baseline† | 76 (75) | 20 (51) | 56 (90) | <0.01 |
| Initial HIV RNA | ||||
| (log10) | 4.2 (3.5–4.7) | 4.3 (3.5–4.9) | 4.1 (3.4–4.6) | 0.21 |
| (copies/mL) | 16,030 (3,370–46,271) | 21,278 (3,370–71,660) | 14,033 (2,500–35,570) | |
| AIDS Diagnosis* | 43 (43) | 23 (60) | 20 (32) | <0.01 |
| Maternal Comorbidity | ||||
| Hepatitis B | 5 (5) | 2 (5) | 3 (5) | 0.95 |
| Hepatitis C | 10 (10) | 2 (5) | 8 (13) | 0.31 |
| Substance Use | 19 (19) | 7 (18) | 12 (19) | 0.86 |
| Depression/mental illness | 28 (28) | 14 (36) | 14 (23) | 0.15 |
Categorical variables are expressed as N (%) and continuous variables are expressed as median (IQR).
*
One missing observation.
†
Women on ART were only included if they were not suppressed after 20 weeks gestation and thus additional ART was added to their regimen or their regimen was switched.